Munoz_p_uhn6520.jpg_thumb90

Pablo Sebastián Muñoz Schuffenegger

Profesor Asociado

Pontificia Universidad Católica de Chile

Santiago, Chile

Líneas de Investigación


Radiation Oncology. Stereotactic Body Radiation Therapy. Gastrointestinal malignancies. Lung Cancer. Imaging- and blood-based biomarkers

Educación

  •  Médico Cirujano, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2009
  •  Radioterapia Oncológica, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2013
  •  High Precision Radiation Therapy, UNIVERSITY OF TORONTO. Canada, 2018

Experiencia Académica

  •   Instructor Adjunto Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicina

    Santiago, Chile

    2013 - 2019

  •   Profesor Asistente Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicina

    Santiago, Chile

    2019 - 2024

  •   Profesor Asociado Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicina

    Chile

    2024 - At present

Experiencia Profesional

  •   Radio Oncólogo Full Time

    Centro de Cáncer Universidad Católica

    Santiago, Chile

    2013 - 2015

  •   Clinical Fellow Full Time

    University of Toronto

    Toronto, Canada

    2015 - 2018

  •   Radio - Oncólogo Full Time

    Centro de Cáncer Universidad Católica

    Santiago, Chile

    2018 - At present

Premios y Distinciones

  •   International Journal of Radiation Oncology, Biology, and Physics - Resident Peer Reviewer Training Program

    American Society of Therapeutic Radiology and Oncology

    Estados Unidos, 2017

    Resident Peer Reviewer Training Program

  •   International Academy Award

    International Association for the Study of Lung Cancer (IASLC)

    Estados Unidos, 2017

    International Association for the Study of Lung Cancer (IASLC) International Academy Award

  •   KCRNC – CUOG Trainee Award

    Kidney Cancer Research Foundation of Canada

    Canada, 2017

    Research Trainee Award

  •   Inaugural Cancer Program Best Fellow Award

    UNIVERSITY OF TORONTO

    Canada, 2018

    Inaugural Cancer Program Best Fellow Award

  •   Excellence in Education by a Trainee Award

    University Health Network (UHN) - Radiation Medicine Program, Princess Margaret Cancer Centre

    Chile, 2019

    Excellence in Education by a Trainee Award


 

Article (21)

Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus
Liver SBRT dose accumulation to assess the impact of anatomic variations on normal tissue doses and toxicity in patients treated with concurrent sorafenib
The Impact of Disease Progression on HealthRelated Quality of Life Outcomes in Patients With Oligometastatic Disease at 12 Months Post Stereotactic Body Radiation Therapy
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion
Management of Primary Hepatic Malignancies During the COVID-19 Pandemic: Recommendations for Risk Mitigation From a Multidisciplinary Perspective
Radiological tumor response and histopathological correlation of hepatocellular carcinoma treated with stereotactic body radiation therapy as a bridge to liver transplantation
A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer
Extensive Unpredictable Pancreas Cancer Inter-fraction Motion: A Case Report
Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls
Practical considerations of lung stereotactic ablative radiotherapy in the developing world
Stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion.
Dosimetry, safety, efficacy and QoL in a study of 5-fraction SBRT for oligometastatic (OM) cancers
Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
Quality of life changes after stereotactic ablative radiotherapy for liver metastases: A prospective cohort analysis
Reasons for Screen Failure among Patients Identified as Candidates for a Phase 2 Study of 5-fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastatic Cancer
Perfusion imaging of colorectal liver metastases treated with bevacizumab and SBRT
Quantifying Health Utilities in Patients Undergoing Stereotactic Body Radiation Treatment for Liver Metastases for Use in Future Economic Evaluations
Radiation-Induced Liver Toxicity
Carcinoma escamoso de la conjuntiva con compromiso extraocular: reporte de caso y revision de la literatura
Central nervous system metastasis secondary to colorectal cancer: a retrospective cohort study of 20 cases
Combined Stereotactic Body Radiation Treatment and Bevacizumab as a Radiosensitizer for Colorectal Liver Metastases

Abstract (1)

What Is the Optimal Radiotherapy Utilization Rate for Lung Cancer? a Systematic Review

BookSection (1)

Stereotactic Body Radiation Therapy for Gastrointestinal Cancers

Proyecto (4)

Stemness-related biomarkers for prediction of neoadjuvant treatment response in locally advanced rectal cancer
Caracterización longitudinal de la microbiota intestinal y su asociación con respuesta oncológica y outcomes reportados por pacientes (PROs) en pacientes con cáncer de recto inferior tratados con terapia neoadyuvante total
Clinical outcomes and novel predictive biomarkers of treatment response in patients with liver cancer treated with stereotactic body radiotherapy
Tumor stroma cells regulate gallbladder cancer progression and chemoresistance

Review (1)

What is the optimal radiotherapy utilization rate for lung cancer? -a systematic review
28
Pablo Muñoz

Profesor Asociado

Hematología-Oncología

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Francisco Acevedo

Medico Oncologo

Hemato Oncologia

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Bruno Nervi

Associated Professor

Hematology - Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile